publication date: Jul. 26, 2019

In Brief

Ohio State forms Pelotonia Institute for Immuno-Oncology

The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has formed the Pelotonia Institute for Immuno-Oncology, a bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at all levels—from prevention to treatment and survivorship. 

Pelotonia, a grassroots cycling event that has raised more than $190 million for cancer research at the OSUCCC–James, has pledged more than $102 million over the next five years. The largest portion of the pledge, $65 million, will directly fund the PIIO, with the remaining dollars continuing to support previously established initiatives, such as Pelotonia Fellowships, Idea Grants, statewide research initiatives, and equipment. The OSUCCC–James is also supporting the PIIO with a $35 million commitment to grow and sustain modern research infrastructure.

Zihai Li, physician scientist and elected member of American Society for Clinical Investigation and Association of American Physicians, has been recruited to lead the new institute. Li joins Ohio State from the Medical University of South Carolina Hollings Cancer Center, where he served as the Sally Abney Rose Endowed Chair in Stem Cell Biology & Therapy, co-leader of the Cancer Immunology program and as chair of the Department of Microbiology and Immunology.

The OSUCCC–James expects to add up to 32 additional faculty over the next five years to work within the PIIO. Multi-phase laboratory renovations will take place during this time to create advanced cellular laboratory facilities, immune monitoring and discovery platforms, immunogenomics, systems immunology, and other research areas for start-up initiatives and national collaborations with other academic centers and industry partners.

“Building this institute is a bold, forward-thinking leap that we … Continue reading Ohio State forms Pelotonia Institute for Immuno-Oncology

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.